Open AccessPersonalized medicine of esophageal cancer
Author(s) -
Lei Wang,
Huiyi Yang,
Yong-Qing Zheng
Publication year - 2012
Publication title -
journal of cancer research and therapeutics/journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/0973-1482.103510
Subject(s) - esophageal cancer , medicine , case fatality rate , oncology , personalized medicine , drug , precision medicine , chemotherapy , cancer , drug response , intensive care medicine , bioinformatics , pathology , epidemiology , pharmacology , biology
The fatality rate of esophageal carcinomas is high in developing countries, making effective treatment desirable. Traditional treatment has now entered into the platform, and treatments based on the detection of biomarkers increasingly become a trend. This review presents several biomarkers of esophageal cancer, including chemotherapy-related biomarkers and targeted drug-related biomarkers, and the correlation of these biomarkers with drug response.